孤儿药物-话题@MedSci - 梅斯（MedSci）

#孤儿药物#

41篇内容 | 1938人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1740115, encodeId=1b531e4011507, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定, objectType=article, longId=182512, objectId=6d2018251202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d2018251202, replyNumber=0, likeNumber=87, createdTime=2020-01-21, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d2018251202, moduleTitle=Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6d2018251202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740092, encodeId=f80d1e40092ad, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=FDA授予OCU400孤儿药物指定以治疗NR2E3突变相关的视网膜退行性疾病, objectType=article, longId=160344, objectId=f03316034403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f03316034403, replyNumber=0, likeNumber=56, createdTime=2019-03-18, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f03316034403, moduleTitle=FDA授予OCU400孤儿药物指定以治疗NR2E3突变相关的视网膜退行性疾病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f03316034403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740096, encodeId=4dce1e400960b, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定, objectType=article, longId=164117, objectId=60a716411e78, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60a716411e78, replyNumber=0, likeNumber=73, createdTime=2019-09-21, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60a716411e78, moduleTitle=囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=60a716411e78)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740100, encodeId=19e01e4010090, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=耐药性慢性粒细胞白血病的治疗契机：FDA已授予SCO-088孤儿药物认定, objectType=article, longId=175076, objectId=bb051e507623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb051e507623, replyNumber=0, likeNumber=97, createdTime=2019-10-13, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb051e507623, moduleTitle=耐药性慢性粒细胞白血病的治疗契机：FDA已授予SCO-088孤儿药物认定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=bb051e507623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740111, encodeId=6d0b1e4011159, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, objectType=article, longId=179454, objectId=c7ad1e945427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ad1e945427, replyNumber=0, likeNumber=65, createdTime=2020-07-29, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ad1e945427, moduleTitle=Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c7ad1e945427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740097, encodeId=45251e400978c, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定, objectType=article, longId=164502, objectId=df0c164502be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df0c164502be, replyNumber=0, likeNumber=69, createdTime=2019-12-11, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df0c164502be, moduleTitle=Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=df0c164502be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740094, encodeId=dd741e40094c1, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定, objectType=article, longId=161780, objectId=3be5161e8072, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3be5161e8072, replyNumber=0, likeNumber=68, createdTime=2019-05-27, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3be5161e8072, moduleTitle=Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3be5161e8072)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740093, encodeId=7dc41e40093c0, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=FDA授予CNP孤儿药物认定用以治疗软骨发育不全, objectType=article, longId=161546, objectId=17ec1615463d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17ec1615463d, replyNumber=0, likeNumber=80, createdTime=2019-12-03, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17ec1615463d, moduleTitle=FDA授予CNP孤儿药物认定用以治疗软骨发育不全, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=17ec1615463d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740105, encodeId=d8021e4010588, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=中心核肌病反义核酸药物DYN101获得FDA孤儿药物指定, objectType=article, longId=177565, objectId=653d1e756528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=653d1e756528, replyNumber=0, likeNumber=56, createdTime=2020-01-02, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=653d1e756528, moduleTitle=中心核肌病反义核酸药物DYN101获得FDA孤儿药物指定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=653d1e756528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740084, encodeId=f4981e40084a8, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Alteogen的抗体-药物偶联物获得FDA孤儿药物认定用于胃癌治疗, objectType=article, longId=146125, objectId=8c3e146125c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c3e146125c7, replyNumber=0, likeNumber=80, createdTime=2018-09-21, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c3e146125c7, moduleTitle=Alteogen的抗体-药物偶联物获得FDA孤儿药物认定用于胃癌治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8c3e146125c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740088, encodeId=c60a1e40088d1, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=FDA授予RGX-181基因疗法孤儿药物资格以治疗2型神经元蜡样脂褐质沉积症, objectType=article, longId=153630, objectId=b07a1536305c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b07a1536305c, replyNumber=0, likeNumber=83, createdTime=2019-04-20, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b07a1536305c, moduleTitle=FDA授予RGX-181基因疗法孤儿药物资格以治疗2型神经元蜡样脂褐质沉积症, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b07a1536305c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740087, encodeId=d1fe1e40087b2, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定, objectType=article, longId=149700, objectId=ed23149e009d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed23149e009d, replyNumber=0, likeNumber=74, createdTime=2018-11-24, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed23149e009d, moduleTitle=Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ed23149e009d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740089, encodeId=bef31e4008981, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=APL-2获得FDA的孤儿药物认定用于治疗C3肾小球病, objectType=article, longId=156443, objectId=a73015644339, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a73015644339, replyNumber=0, likeNumber=71, createdTime=2019-11-08, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a73015644339, moduleTitle=APL-2获得FDA的孤儿药物认定用于治疗C3肾小球病, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a73015644339)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740090, encodeId=4f841e40090f1, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=MB-102（CD123 CAR T）获得FDA孤儿药物指定用于治疗浆细胞样树突状细胞肿瘤, objectType=article, longId=156453, objectId=e4e31564538b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4e31564538b, replyNumber=0, likeNumber=91, createdTime=2019-05-04, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4e31564538b, moduleTitle=MB-102（CD123 CAR T）获得FDA孤儿药物指定用于治疗浆细胞样树突状细胞肿瘤, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e4e31564538b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740091, encodeId=22411e40091ae, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=PledPharma在美国为Aladote申请孤儿药物认定, objectType=article, longId=156684, objectId=4954156684c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4954156684c0, replyNumber=0, likeNumber=85, createdTime=2019-12-02, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4954156684c0, moduleTitle=PledPharma在美国为Aladote申请孤儿药物认定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4954156684c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740082, encodeId=3bd41e4008205, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=欧盟对Trovagene的PCM-075孤儿药物认定持积极意见, objectType=article, longId=145740, objectId=e50a145e400e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e50a145e400e, replyNumber=0, likeNumber=104, createdTime=2018-11-08, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e50a145e400e, moduleTitle=欧盟对Trovagene的PCM-075孤儿药物认定持积极意见, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e50a145e400e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740083, encodeId=f83f1e400839e, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定, objectType=article, longId=145959, objectId=fbd114595986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbd114595986, replyNumber=0, likeNumber=85, createdTime=2019-05-02, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbd114595986, moduleTitle=美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fbd114595986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740081, encodeId=9fb71e40081be, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Asceneuron的ASN120290从FDA获得了进行性核上性麻痹的孤儿药物认定, objectType=article, longId=145483, objectId=2897145483bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2897145483bf, replyNumber=0, likeNumber=54, createdTime=2019-04-10, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2897145483bf, moduleTitle=Asceneuron的ASN120290从FDA获得了进行性核上性麻痹的孤儿药物认定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2897145483bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740086, encodeId=dc1e1e400868a, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=Cytori 旗下ATI-1123获得FDA孤儿药物认定, objectType=article, longId=149087, objectId=990a14908e6b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=990a14908e6b, replyNumber=0, likeNumber=59, createdTime=2018-10-17, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=990a14908e6b, moduleTitle=Cytori 旗下ATI-1123获得FDA孤儿药物认定, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=990a14908e6b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1740085, encodeId=80781e4008575, content=<a href='/topic/show?id=f5a445431df' target=_blank style='color:#2F92EE;'>#孤儿药物#</a>, objectTitle=PLN-74809获得FDA孤儿药物认定用于治疗特发性肺纤维化, objectType=article, longId=146127, objectId=56de14612e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56de14612e03, replyNumber=0, likeNumber=61, createdTime=2019-01-25, rootId=0, userName=ms6980045490879608, userId=a4f034650217, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56de14612e03, moduleTitle=PLN-74809获得FDA孤儿药物认定用于治疗特发性肺纤维化, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=56de14612e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

孤儿药物

2020-05-29

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Autolus的快速解离型CAR-T细胞疗法治疗急性淋巴细胞白血病，获FDA孤儿药物指定

2020-01-21

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

FDA授予OCU400孤儿药物指定以治疗NR2E3突变相关的视网膜退行性疾病

2019-03-18

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

囊性纤维化候选药物SNSP113获得欧盟孤儿药物认定

2019-09-21

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

耐药性慢性粒细胞白血病的治疗契机：FDA已授予SCO-088孤儿药物认定

2019-10-13

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Satralizumab获得日本孤儿药物认定，用以治疗视网膜神经脊髓炎和神经脊髓炎视觉障碍

2020-07-29

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Viracta的HDAC抑制剂nanatinostat治疗EBV相关癌症，获得美国FDA的孤儿药物指定

2019-12-11

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Mitochon Pharmaceuticals的MP-101治疗亨廷顿舞蹈病获得FDA孤儿药物指定

2019-05-27

hb2008ye (审核中...)

前往app查看评论内容

#孤儿药物#

FDA授予CNP孤儿药物认定用以治疗软骨发育不全

2019-12-03

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

中心核肌病反义核酸药物DYN101获得FDA孤儿药物指定

2020-01-02

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Alteogen的抗体-药物偶联物获得FDA孤儿药物认定用于胃癌治疗

2018-09-21

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

FDA授予RGX-181基因疗法孤儿药物资格以治疗2型神经元蜡样脂褐质沉积症

2019-04-20

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Portola口服Syk/JAK抑制剂Cerdlatinib治疗外周T细胞淋巴瘤获得FDA孤儿药物指定

2018-11-24

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

APL-2获得FDA的孤儿药物认定用于治疗C3肾小球病

2019-11-08

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

MB-102（CD123 CAR T）获得FDA孤儿药物指定用于治疗浆细胞样树突状细胞肿瘤

2019-05-04

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

PledPharma在美国为Aladote申请孤儿药物认定

2019-12-02

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

欧盟对Trovagene的PCM-075孤儿药物认定持积极意见

2018-11-08

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定

2019-05-02

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Asceneuron的ASN120290从FDA获得了进行性核上性麻痹的孤儿药物认定

2019-04-10

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

Cytori 旗下ATI-1123获得FDA孤儿药物认定

2018-10-17

ms6980045490879608 (审核中...)

前往app查看评论内容

#孤儿药物#

PLN-74809获得FDA孤儿药物认定用于治疗特发性肺纤维化

2019-01-25

科室
- - 订阅+
  - 更多科室
工具
服务